COST OF TREATMENT WITH BIOSIMILARS - CASE WITH RITUXIMAB IN ONCOHEMATOLOGY

被引：0
|
作者：
Boncheva, E. [1 ]
Cherneva, D. [2 ]
Benisheva, T. [1 ]
机构：
[1] Med Univ Sofia, Sofia, Bulgaria
[2] Bulgarian Assoc Drug Informat, Sofia, Bulgaria
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC209
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [1] Biologicals and Biosimilars in Hematology: The Case of Rituximab
    Vulto, Arnold G.
    HEMASPHERE, 2019, 3 (06):
  • [2] Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan
    Halawah, Hala H. H.
    Alkhatib, Nimer S. S.
    Almutairi, Abdulaali R. R.
    Saleh, Mohammad
    Halloush, Shiraz S. S.
    Rashdan, Omar
    Masadh, Lama
    Abusara, Osama H. H.
    Abraham, Ivo
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 835 - 842
  • [3] Rituximab biosimilars
    Vital, Edward M.
    Kay, Jonathan
    Emery, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 1049 - 1062
  • [4] The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
    Giuliani, Jacopo
    Bonetti, Andrea
    ANTICANCER RESEARCH, 2019, 39 (07) : 3971 - 3973
  • [5] Rituximab biosimilars in clinical practice
    Jurczak, Wojciech
    Dlugosz-Danecka, Monika
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1523 - 1524
  • [6] Rituximab biosimilars for lymphoma in Europe
    Jurczak, Wojciech
    Danecka, Monika Dlugosz
    Buske, Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) : 1045 - 1056
  • [7] Biosimilars Have Arrived: Rituximab
    Greenwald, Maria
    Tesser, John
    Sewell, K. Lea
    ARTHRITIS, 2018,
  • [8] Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape
    Subramanian, Janakiraman
    Cavenagh, Jamie
    Desai, Bhardwaj
    Jacobs, Ira
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 131 - 140
  • [9] ANALYSIS OF THE COST OF ONCOHEMATOLOGY DISEASES IN BULGARIA
    Tachkov, K.
    Kamusheva, M.
    Mitov, K.
    Doneva, M.
    Petrova, G.
    VALUE IN HEALTH, 2019, 22 : S75 - S76
  • [10] The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars
    Brown, Jennifer R.
    Cymbalista, Florence
    Sharman, Jeff
    Jacobs, Ira
    Nava-Parada, Pilar
    Mato, Anthony
    ONCOLOGIST, 2018, 23 (03): : 288 - 296
12345